Cargando…
On the Right Track to Treat Movement Disorders: Promising Therapeutic Approaches for Parkinson’s and Huntington’s Disease
Movement disorders are neurological conditions in which patients manifest a diverse range of movement impairments. Distinct structures within the basal ganglia of the brain, an area involved in movement regulation, are differentially affected for every disease. Among the most studied movement disord...
Autores principales: | Troncoso-Escudero, Paulina, Sepulveda, Denisse, Pérez-Arancibia, Rodrigo, Parra, Alejandra V., Arcos, Javiera, Grunenwald, Felipe, Vidal, Rene L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497570/ https://www.ncbi.nlm.nih.gov/pubmed/33101007 http://dx.doi.org/10.3389/fnagi.2020.571185 |
Ejemplares similares
-
Small molecules to perform big roles: The search for Parkinson's and Huntington's disease therapeutics
por: Pérez-Arancibia, Rodrigo, et al.
Publicado: (2023) -
Insulin-like growth factor 2 and autophagy gene expression alteration arise as potential biomarkers in Parkinson’s disease
por: Sepúlveda, Denisse, et al.
Publicado: (2022) -
Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease
por: Troncoso-Escudero, Paulina, et al.
Publicado: (2018) -
Contribution of Autophagy-Lysosomal Pathway in the Exosomal Secretion of Alpha-Synuclein and Its Impact in the Progression of Parkinson’s Disease
por: Sepúlveda, Denisse, et al.
Publicado: (2022) -
IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models
por: Arcos, Javiera, et al.
Publicado: (2023)